Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
25.71%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 1.58Close
$ 0.26 - $ 1.84 52-Week Range
Ticker Information
Ticker
OVIDCompany Name
OVID THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQOVID THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
OVID - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 1.71M | 25.71% | $ 6.65M |
| 3/31/2025 | $ 1.74M | 316.97% | $ 548K |
| 12/31/2024 | $ 1.71M | 302.12% | $ 566K |
| 9/30/2024 | $ 1.67M | 264.33% | $ 631.56K |
| 6/30/2024 | $ 1.63M | 286.48% | $ 567.53K |
| 3/31/2024 | $ 1.6M | 338.01% | $ 473.54K |
| 12/31/2023 | $ 1.6M | 407.61% | $ 391.69K |
| 9/30/2023 | $ 1.64M | 551.64% | $ 296.41K |
| 6/30/2023 | $ 1.65M | 830.07% | $ 198.54K |
| 3/31/2023 | $ 1.71M | 1380.71% | $ 123.54K |
Key Performance Insights, Last 5 Years
- OVID THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 4.02%.
- Over the past 5 years, OVID THERAPEUTICS INC's average DepAmor % has been 246.57%.
- The median DepAmor % for OVID THERAPEUTICS INC during this period was 80.25%
- OVID THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 1380.71%.
- The lowest DepAmor % recorded by OVID THERAPEUTICS INC in the same timeframe 0.11%
OVID THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for OVID THERAPEUTICS INC is calculated as follows: DepAmor [ $ 277.61K ] / Revenues [ $ 6.91M ]
(=) DepAmor % [ 4.02% ] OVID - Depreciation and Amortization Margin, Last 5 years
0.11%
Minimum
Dec 31, 2021
1380.71%
Maximum
Mar 31, 2023
246.57%
Average
80.25%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |